More recently, a test called “EsoGuard”, which is based on the methylation analysis of CCNA1 and VIM genes in brush cells for the detection of Barrett’s esophagus, which is the precursor and a major risk factor for esophageal adenocarcinoma, has recently received CE-IVD certification [112]. This evidence concerns the gene CCNA1 and esophageal adenocarcinoma.